Sandu Pharmaceuticals
₹56.00
-0.33 (-0.59%)
05 November, 2024 03:21 BSE: 524703
NSE: SANDUPHQISIN: INE751D01014
Start SIP in Sandu Pharmaceuticals
Start SIPSandu Pharmaceuticals Performance
Day Range
52 Week Range
Sandu Pharmaceuticals Technicals
EMA & SMA
Current Price
₹56.00
-0.33 (-0.59%)
- Bullish Moving Average
- ___
- 3
- Bearish Moving Average
- ___
- 13
- 20 Day
- ₹57.06
- 50 Day
- ₹58.84
- 100 Day
- ₹60.01
- 200 Day
- ₹61.30
- 20 Day
- ₹57.33
- 50 Day
- ₹60.01
- 100 Day
- ₹60.04
- 200 Day
- ₹62.35
Sandu Pharmaceuticals Resistance and Support
PIVOT
₹55.57
Resistance | |
---|---|
First Resistance | 56.49 |
Second Resistance | 57.30 |
Third Resistance | 58.22 |
RSI | 41.57 |
MFI | 58.93 |
MACD Single Line | -1.33 |
MACD | -1.35 |
Support | |
---|---|
First Support | 54.76 |
Second Support | 53.84 |
Third Supoort | 53.03 |
Sandu Pharmaceuticals Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 6,560 | 567,899 | 86.57 |
Week | 3,944 | 324,197 | 82.2 |
1 Month | 5,141 | 396,232 | 77.08 |
6 Month | 10,103 | 751,875 | 74.42 |
Sandu Pharmaceuticals Result Highlights
Sandu Pharmaceuticals Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Sandu Pharmaceuticals Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-11-14 | Quarterly Results | |
2024-08-12 | Quarterly Results & Final Dividend | |
2024-06-05 | Audited Results | (Revised) per share(5%)Dividend |
2024-03-30 | Others | Inter alia, to consider : 1. To Consider and Appoint Chief Financial Officer of the Company. per share(5%)Dividend |
2024-02-14 | Quarterly Results |